- Home
- IDYA vs BANC Comparison
IDYA vs BANC Comparison
Compare IDYA & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- BANC
- Stock Information
- Founded
- IDYA 2015
- BANC 1941
- Country
- IDYA United States
- BANC United States
- Employees
- IDYA N/A
- BANC N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- BANC Major Banks
- Sector
- IDYA Health Care
- BANC Finance
- Exchange
- IDYA Nasdaq
- BANC Nasdaq
- Market Cap
- IDYA 2.3B
- BANC 2.3B
- IPO Year
- IDYA 2019
- BANC N/A
- Fundamental
- Price
- IDYA $27.16
- BANC $16.84
- Analyst Decision
- IDYA Buy
- BANC Buy
- Analyst Count
- IDYA 14
- BANC 11
- Target Price
- IDYA $49.17
- BANC $17.18
- AVG Volume (30 Days)
- IDYA 953.6K
- BANC 1.9M
- Earning Date
- IDYA 11-03-2025
- BANC 10-21-2025
- Dividend Yield
- IDYA N/A
- BANC 2.37%
- EPS Growth
- IDYA N/A
- BANC N/A
- EPS
- IDYA N/A
- BANC 0.65
- Revenue
- IDYA $7,000,000.00
- BANC $949,659,000.00
- Revenue This Year
- IDYA $62.30
- BANC $7.25
- Revenue Next Year
- IDYA $285.58
- BANC $10.78
- P/E Ratio
- IDYA N/A
- BANC $26.00
- Revenue Growth
- IDYA N/A
- BANC 150.32
- 52 Week Low
- IDYA $13.45
- BANC $11.52
- 52 Week High
- IDYA $39.30
- BANC $18.08
- Technical
- Relative Strength Index (RSI)
- IDYA 70.30
- BANC 68.12
- Support Level
- IDYA $24.04
- BANC $16.52
- Resistance Level
- IDYA $25.39
- BANC $17.01
- Average True Range (ATR)
- IDYA 1.05
- BANC 0.33
- MACD
- IDYA 0.16
- BANC 0.06
- Stochastic Oscillator
- IDYA 99.45
- BANC 79.61
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.